Global Schizophrenia Therapeutics Market Research Report 2023

Report ID: 1899998 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Schizophrenia Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 First-Generation Antipsychotic Drugs
        1.2.3 Second-Generation Antipsychotic Drugs
        1.2.4 Third-Generation Antipsychotic Drugs
    1.3 Market by Application
        1.3.1 Global Schizophrenia Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Schizophrenia Therapeutics Market Perspective (2017-2028)
    2.2 Schizophrenia Therapeutics Growth Trends by Region
        2.2.1 Schizophrenia Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Schizophrenia Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Schizophrenia Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Schizophrenia Therapeutics Market Dynamics
        2.3.1 Schizophrenia Therapeutics Industry Trends
        2.3.2 Schizophrenia Therapeutics Market Drivers
        2.3.3 Schizophrenia Therapeutics Market Challenges
        2.3.4 Schizophrenia Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Schizophrenia Therapeutics Players by Revenue
        3.1.1 Global Top Schizophrenia Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Schizophrenia Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Schizophrenia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Schizophrenia Therapeutics Revenue
    3.4 Global Schizophrenia Therapeutics Market Concentration Ratio
        3.4.1 Global Schizophrenia Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Schizophrenia Therapeutics Revenue in 2021
    3.5 Schizophrenia Therapeutics Key Players Head office and Area Served
    3.6 Key Players Schizophrenia Therapeutics Product Solution and Service
    3.7 Date of Enter into Schizophrenia Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Schizophrenia Therapeutics Breakdown Data by Type
    4.1 Global Schizophrenia Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Schizophrenia Therapeutics Forecasted Market Size by Type (2023-2028)
5 Schizophrenia Therapeutics Breakdown Data by Application
    5.1 Global Schizophrenia Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Schizophrenia Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Schizophrenia Therapeutics Market Size (2017-2028)
    6.2 North America Schizophrenia Therapeutics Market Size by Country (2017-2022)
    6.3 North America Schizophrenia Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Schizophrenia Therapeutics Market Size (2017-2028)
    7.2 Europe Schizophrenia Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Schizophrenia Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Schizophrenia Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Schizophrenia Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Schizophrenia Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Schizophrenia Therapeutics Market Size (2017-2028)
    9.2 Latin America Schizophrenia Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Schizophrenia Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Schizophrenia Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Schizophrenia Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Schizophrenia Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Detail
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Schizophrenia Therapeutics Introduction
        11.1.4 AstraZeneca Revenue in Schizophrenia Therapeutics Business (2017-2022)
        11.1.5 AstraZeneca Recent Development
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Detail
        11.2.2 Eli Lilly Business Overview
        11.2.3 Eli Lilly Schizophrenia Therapeutics Introduction
        11.2.4 Eli Lilly Revenue in Schizophrenia Therapeutics Business (2017-2022)
        11.2.5 Eli Lilly Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Detail
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Schizophrenia Therapeutics Introduction
        11.3.4 GlaxoSmithKline Revenue in Schizophrenia Therapeutics Business (2017-2022)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Detail
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Schizophrenia Therapeutics Introduction
        11.4.4 Johnson & Johnson Revenue in Schizophrenia Therapeutics Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Alkermes
        11.5.1 Alkermes Company Detail
        11.5.2 Alkermes Business Overview
        11.5.3 Alkermes Schizophrenia Therapeutics Introduction
        11.5.4 Alkermes Revenue in Schizophrenia Therapeutics Business (2017-2022)
        11.5.5 Alkermes Recent Development
    11.6 AbbVie
        11.6.1 AbbVie Company Detail
        11.6.2 AbbVie Business Overview
        11.6.3 AbbVie Schizophrenia Therapeutics Introduction
        11.6.4 AbbVie Revenue in Schizophrenia Therapeutics Business (2017-2022)
        11.6.5 AbbVie Recent Development
    11.7 Amgen
        11.7.1 Amgen Company Detail
        11.7.2 Amgen Business Overview
        11.7.3 Amgen Schizophrenia Therapeutics Introduction
        11.7.4 Amgen Revenue in Schizophrenia Therapeutics Business (2017-2022)
        11.7.5 Amgen Recent Development
    11.8 Bristol-Myers Squibb
        11.8.1 Bristol-Myers Squibb Company Detail
        11.8.2 Bristol-Myers Squibb Business Overview
        11.8.3 Bristol-Myers Squibb Schizophrenia Therapeutics Introduction
        11.8.4 Bristol-Myers Squibb Revenue in Schizophrenia Therapeutics Business (2017-2022)
        11.8.5 Bristol-Myers Squibb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Schizophrenia Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of First-Generation Antipsychotic Drugs
    Table 3. Key Players of Second-Generation Antipsychotic Drugs
    Table 4. Key Players of Third-Generation Antipsychotic Drugs
    Table 5. Global Schizophrenia Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Schizophrenia Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Schizophrenia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Schizophrenia Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Schizophrenia Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Schizophrenia Therapeutics Market Share by Region (2023-2028)
    Table 11. Schizophrenia Therapeutics Market Trends
    Table 12. Schizophrenia Therapeutics Market Drivers
    Table 13. Schizophrenia Therapeutics Market Challenges
    Table 14. Schizophrenia Therapeutics Market Restraints
    Table 15. Global Schizophrenia Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Schizophrenia Therapeutics Market Share by Players (2017-2022)
    Table 17. Global Top Schizophrenia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Schizophrenia Therapeutics as of 2021)
    Table 18. Ranking of Global Top Schizophrenia Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Schizophrenia Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Schizophrenia Therapeutics Product Solution and Service
    Table 22. Date of Enter into Schizophrenia Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Schizophrenia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Schizophrenia Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Schizophrenia Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Schizophrenia Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Schizophrenia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Schizophrenia Therapeutics Revenue Market Share by Application (2017-2022)
    Table 30. Global Schizophrenia Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Schizophrenia Therapeutics Revenue Market Share by Application (2023-2028)
    Table 32. North America Schizophrenia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Schizophrenia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Schizophrenia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Schizophrenia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Schizophrenia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Schizophrenia Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Schizophrenia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Schizophrenia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Schizophrenia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Schizophrenia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. AstraZeneca Company Detail
    Table 43. AstraZeneca Business Overview
    Table 44. AstraZeneca Schizophrenia Therapeutics Product
    Table 45. AstraZeneca Revenue in Schizophrenia Therapeutics Business (2017-2022) & (US$ Million)
    Table 46. AstraZeneca Recent Development
    Table 47. Eli Lilly Company Detail
    Table 48. Eli Lilly Business Overview
    Table 49. Eli Lilly Schizophrenia Therapeutics Product
    Table 50. Eli Lilly Revenue in Schizophrenia Therapeutics Business (2017-2022) & (US$ Million)
    Table 51. Eli Lilly Recent Development
    Table 52. GlaxoSmithKline Company Detail
    Table 53. GlaxoSmithKline Business Overview
    Table 54. GlaxoSmithKline Schizophrenia Therapeutics Product
    Table 55. GlaxoSmithKline Revenue in Schizophrenia Therapeutics Business (2017-2022) & (US$ Million)
    Table 56. GlaxoSmithKline Recent Development
    Table 57. Johnson & Johnson Company Detail
    Table 58. Johnson & Johnson Business Overview
    Table 59. Johnson & Johnson Schizophrenia Therapeutics Product
    Table 60. Johnson & Johnson Revenue in Schizophrenia Therapeutics Business (2017-2022) & (US$ Million)
    Table 61. Johnson & Johnson Recent Development
    Table 62. Alkermes Company Detail
    Table 63. Alkermes Business Overview
    Table 64. Alkermes Schizophrenia Therapeutics Product
    Table 65. Alkermes Revenue in Schizophrenia Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Alkermes Recent Development
    Table 67. AbbVie Company Detail
    Table 68. AbbVie Business Overview
    Table 69. AbbVie Schizophrenia Therapeutics Product
    Table 70. AbbVie Revenue in Schizophrenia Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. AbbVie Recent Development
    Table 72. Amgen Company Detail
    Table 73. Amgen Business Overview
    Table 74. Amgen Schizophrenia Therapeutics Product
    Table 75. Amgen Revenue in Schizophrenia Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Amgen Recent Development
    Table 77. Bristol-Myers Squibb Company Detail
    Table 78. Bristol-Myers Squibb Business Overview
    Table 79. Bristol-Myers Squibb Schizophrenia Therapeutics Product
    Table 80. Bristol-Myers Squibb Revenue in Schizophrenia Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Bristol-Myers Squibb Recent Development
    Table 82. Research Programs/Design for This Report
    Table 83. Key Data Information from Secondary Sources
    Table 84. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Schizophrenia Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. First-Generation Antipsychotic Drugs Features
    Figure 3. Second-Generation Antipsychotic Drugs Features
    Figure 4. Third-Generation Antipsychotic Drugs Features
    Figure 5. Global Schizophrenia Therapeutics Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Other Case Studies
    Figure 9. Schizophrenia Therapeutics Report Years Considered
    Figure 10. Global Schizophrenia Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Schizophrenia Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Schizophrenia Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Schizophrenia Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Schizophrenia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Schizophrenia Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Schizophrenia Therapeutics Revenue in 2021
    Figure 16. North America Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Schizophrenia Therapeutics Market Share by Country (2017-2028)
    Figure 18. United States Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Schizophrenia Therapeutics Market Share by Country (2017-2028)
    Figure 22. Germany Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Schizophrenia Therapeutics Market Share by Region (2017-2028)
    Figure 30. China Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Schizophrenia Therapeutics Market Share by Country (2017-2028)
    Figure 38. Mexico Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Schizophrenia Therapeutics Market Share by Country (2017-2028)
    Figure 42. Turkey Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Schizophrenia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. AstraZeneca Revenue Growth Rate in Schizophrenia Therapeutics Business (2017-2022)
    Figure 45. Eli Lilly Revenue Growth Rate in Schizophrenia Therapeutics Business (2017-2022)
    Figure 46. GlaxoSmithKline Revenue Growth Rate in Schizophrenia Therapeutics Business (2017-2022)
    Figure 47. Johnson & Johnson Revenue Growth Rate in Schizophrenia Therapeutics Business (2017-2022)
    Figure 48. Alkermes Revenue Growth Rate in Schizophrenia Therapeutics Business (2017-2022)
    Figure 49. AbbVie Revenue Growth Rate in Schizophrenia Therapeutics Business (2017-2022)
    Figure 50. Amgen Revenue Growth Rate in Schizophrenia Therapeutics Business (2017-2022)
    Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Schizophrenia Therapeutics Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Alkermes
AbbVie
Amgen
Bristol-Myers Squibb
Frequently Asked Questions
Schizophrenia Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Schizophrenia Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Schizophrenia Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports